Satyajit Kosuri to Triazines
This is a "connection" page, showing publications Satyajit Kosuri has written about Triazines.
Connection Strength
0.179
-
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib. Br J Haematol. 2020 07; 190(1):e48-e51.
Score: 0.179